Skip to main content
    M

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $0.63
    -0.03 (-4.37%)

    Market Cap: $27.73M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to MIRA Pharmaceuticals, Inc. Common Stock are Telomir Pharmaceuticals, Inc. Common Stock (TELO), Scilex Holding Company (SCLX) and TherapeuticsMD (TXMD). By market cap, MIRA Pharmaceuticals, Inc. Common Stock ranks 9th of the 13 companies on this page; Mereo BioPharma Group PLC ADR (MREO) is the largest at $49.11M.

    Peer Comparison

    MIRA's revenue growth of 0.0% is above the peer median of -0.2%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    MIRA Pharmaceuticals, Inc. Common Stock (MIRA)$27.73MN/AN/A0.0%N/A0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Scilex Holding Company (SCLX)$10.06MN/A0.3x0.0%143.5%-22.8%0.00%
    TherapeuticsMD Inc (TXMD)$21.64MN/A5.6x-6.6%N/A-8.7%0.00%
    Mereo BioPharma Group PLC ADR (MREO)$49.11MN/A61.3x0.0%-116.6%0.0%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Marker Therapeutics Inc (MRKR)$14.51MN/A14.5x-245.5%N/A-51.0%0.00%
    InspireMD Inc (NSPR)$30.13MN/A4.9x0.0%-163.8%-0.4%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    ProMIS Neurosciences Inc. (PMN)$29.60MN/AN/A0.0%N/A0.0%0.00%
    Mural Oncology plc (MURA)$35.38MN/AN/A0.0%-173.6%0.0%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Peer median$29.87MN/A5.6x0.0%-163.8%-0.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to MIRA Pharmaceuticals, Inc. Common Stock, ranked by how closely their business, size, sector and industry match. The largest group, 9 of the 12, is in Biotechnology; the other 3 span 3 industries.

    CompanyAboutPeers
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)Biotechnology
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Scilex Holding Company (SCLX)Drug Manufacturers - General
    Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain.
    SCLX competitors
    TherapeuticsMD Inc (TXMD)Drug Manufacturers - Specialty & Generic
    TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.
    TXMD competitors
    Mereo BioPharma Group PLC ADR (MREO)Biotechnology
    Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases...
    MREO competitors
    INmune Bio Inc (INMB)Biotechnology
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Marker Therapeutics Inc (MRKR)Biotechnology
    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based...
    MRKR competitors
    InspireMD Inc (NSPR)Medical Devices
    InspireMD, Inc., a medical device company, is focused on the development and commercialization of proprietary MicroNet stent platform technology...
    NSPR competitors
    Plus Therapeutics Inc (PSTV)Biotechnology
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    ImageneBio, Inc. (IMA)Biotechnology
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    ProMIS Neurosciences Inc. (PMN)Biotechnology
    ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases...
    PMN competitors
    Mural Oncology plc (MURA)Biotechnology
    Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors...
    NextCure Inc (NXTC)Biotechnology
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors

    Frequently Asked Questions About MIRA

    Who are MIRA Pharmaceuticals, Inc. Common Stock's main competitors?

    The companies most similar to MIRA Pharmaceuticals, Inc. Common Stock include Telomir Pharmaceuticals, Inc. Common Stock (TELO), Scilex Holding Company (SCLX), TherapeuticsMD (TXMD), Mereo BioPharma Group PLC ADR (MREO) and INmune Bio (INMB), listed from the closest match.

    Who is MIRA Pharmaceuticals, Inc. Common Stock's biggest competitor?

    Mereo BioPharma Group PLC ADR (MREO) is the largest of the similar companies at $49.11M; Telomir Pharmaceuticals, Inc. Common Stock (TELO) is the closest match by business profile, size, sector and industry.

    How does MIRA stock compare with its competitors?

    MIRA's net margin is 0.0% against a peer median of 0.0%.

    Which of MIRA Pharmaceuticals, Inc. Common Stock's competitors pays a higher dividend?

    MIRA Pharmaceuticals, Inc. Common Stock pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is MIRA Pharmaceuticals, Inc. Common Stock bigger than its competitors?

    No. MIRA Pharmaceuticals, Inc. Common Stock is 9th by market cap among the 13 companies on this page; the largest is Mereo BioPharma Group PLC ADR (MREO) at $49.11M.